Federica Benvenuti - Photo by Rocco Ceselin for Nature

Paving the way for new lung cancer therapy

March 13, 2024: New perspectives for lung cancer immunotherapy emerge from data just published, in the prestigious journal Nature Communications, by the research group led by Dr. Federica Benvenuti at the ICGEB in Trieste, Italy. The study was supported by AIRC Foundation for Cancer Research.

Read More
Mutant p53 induces serine/glycine synthesis and essential amino acids intake sustaining a metabolic adaptive response that promotes breast cancer growth.

Latest in Science

Publications and funding: an overview of some of the high-impact scientific papers published by ICGEB PIs in scientific journals this last quarter, and grants received, focusing on studies in Health.

Read More